Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

IP-10 PRODUCTION BY THE LYMPH NODES MEDIATES ENTRY OF SIV-SPECIFIC CXCR3+CD8+ T CELLS

By Enthusiast Inc MDMarch 5, 2019

…node mononuclear cells (LNMC) from the vaccinated animals stimulated ex vivo with SEB and IFNγ was measured by ELISA, multiplex chemiluminescence detection assays (MSD) and intracellular staining. High magnitude (up…

LYMPH NODE TREG SUBSETS ARE EXPANDED IN SOME HIV+ PEOPLE ON SUPPRESSIVE ART

By Enthusiast Inc MDMarch 5, 2019

…trend was seen for TFR within follicles (medians, 59 versus 22 cells/mm2; p=0.10). In ART treated HIV+, Tregs (median, 36 cells/mm2) and TFR (median, 76 cells/mm2) did not differ significantly…

Single Cell Transcriptome Sequencing of Human Lymph Node HIV-Infected CD4 Cells

By Enthusiast Inc MDFebruary 16, 2016

Identification of live HIV-infected CD4 cells allows the characterization of individual cells both by flow cytometry and by transcriptomic analysis. Cervical lymph nodes were obtained from 3 viremic HIV-infected volunteers, median…

Clones of SIV-Infected Cells Are Present in Spleen and Lymph Nodes in Rhesus Macaques

By Enthusiast Inc MDFebruary 16, 2016

…samples that can be obtained from patients, we developed a model using SIV-infected rhesus macaques. The methods of Maldarelli et al (Science 345: 179, 2014) were used to generate an…

Follicular CTL Accumulate in SIV-Infected Lymph Nodes Due to Immune Activation

By Enthusiast Inc MDFebruary 16, 2016

…of Granzyme B and exert a higher capacity to mediate in vitro bispecific-mediated redirected killing of infected cells. Chronically infected AGM, on the other hand, did not accumulate fCD8. Fluidigm…

THE PrEP CASCADE AT NYC SEXUAL HEALTH CLINICS: NAVIGATION IS THE KEY TO UPTAKE

By Enthusiast Inc MDMarch 5, 2018

…care. Our aim was to understand uptake of this intervention and related patient-level factors, which is critical to improving the PrEP cascade. We analyzed medical record data for HIV-negative men…

HIV-1 Combinectin BMS-986197: A Long-Acting Inhibitor With Multiple Modes of Action

By Enthusiast Inc MDFebruary 16, 2016

…anti-gp41 Adnectin was joined at its amino terminus to the anti-CD4 Adnectin via a peptide linker. A third inhibitor, an alpha-helical peptide fusion inhibitor, was linked to the carboxy end…

SINGLE-CELL RNAflow-FISH REVEALS TRANSCRIPTIONAL DIVERSITY FOLLOWING LATENCY REVERSAL

By Jimmy He PharmD, DScApril 22, 2021

…co-expressed gag and nef RNA. Reactivated cells were dominated by transcriptionally heterogeneous vRNA+p24- cells: gag+nef- (median 47%) > gag-nef+ (median 30%) > gag+nef+ (median 12%). PEP005 and panobinostat resulted in…

The Specificity of V3 Antibodies in RV144 Plasma Implicated in Reducing HIV Infection

By Enthusiast Inc MDSeptember 29, 2014

…placebo recipients were tested in ELISA at a 1:100 dilution for reactivity vs. biotinylated cyclic V3 peptides (cV3s). Results: Of 8 cyclic V3 peptides studied, reactivity was strongest vs. clade…

BIC/FTC/TAF POSTEXPOSURE PROPHYLAXIS PROTECTS MACAQUES AGAINST RECTAL SHIV INFECTION

By Jimmy He PharmD, DScApril 28, 2020

Current guidelines recommend 4 weeks of daily ARVs for post-exposure prophylaxis (PEP) after an HIV exposure, though the optimal duration of PEP is not known. An effective short-course regimen could…

←1
2345678910111213141516171819
…2021222324…
25262728293031323334353637383940414243444546474849505152535455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top